Combination of Hydroxychloroquine, Melatonin and Mercaptopurine as a Possible Intervention for Prophylaxis and Treatment of Novel COVID-19 Infection

Author(s): Gyan Vardhan, Vikas Kumar, Megha Agrawal, Puneet Dhamija*

Journal Name: Coronaviruses
The World's First International Journal Dedicated to Coronaviruses

Volume 2 , Issue 4 , 2021


Become EABM
Become Reviewer
Call for Editor

Abstract:

Background: COVID-19 has been declared as a pandemic recently and has caused many deaths worldwide. Till date, no effective drug or vaccine is available against SARS-CoV-2. There is an urgent need to find effective alternative preventive and treatment strategies to deal with the SARS-CoV- 2 outbreak.

Objective: This communication proposes a new potential drug combination (repurposed) for prophylaxis and treatment of SARS-CoV-2.

Methods and Materials: We performed a brief review of literature on a combination of Hydroxychloroquine, Melatonin and Mercaptopurine for prophylaxis and treatment of Novel COVID-19 infection and also assessed their possible mechanism of action against SARS-CoV-2.

Observation: Proposed combination seems to be safe, and the target is unlikely to develop resistance to this combination.

Conclusion: This scientific review proposes potential candidate repurposed drugs and potential drug combinations targeting 2019-nCoV/SARS-CoV-2.

Keywords: Novel COVID-19, Hydroxychloroquine, Melatonin, Mercaptopurine, coronavirus, Prophylaxis.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 2
ISSUE: 4
Year: 2021
Published on: 31 May, 2021
Page: [415 - 418]
Pages: 4
DOI: 10.2174/2666796701999201016154957

Article Metrics

PDF: 7